NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented at the American Diabetes Association Scientific Sessions.In the STRIVE trial, researchers assessed glycemic outcomes, insulin delivery and device usage among people with type 1 or type 2 diabetes using the

Children with type 1 diabetes had similar long-term glycemic outcomes with two different automated insulin delivery systems, researchers reported in a paper published in Diabetes…

NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented…